Lite Strategy, INC. (LITS) SEC Filings — 2025
18 SEC filings for Lite Strategy, INC. (LITS) in 2025.
Filings
- Lite Strategy Inc. Announces Director Changes — 8-K · Dec 30, 2025
- Lite Strategy, Inc. Changes Certifying Accountant — 8-K · Dec 5, 2025
- Lite Strategy, Inc. Amends 8-K Filing — 8-K/A · Nov 20, 2025
- Lite Strategy, Inc. Reports Board and Officer Changes — 8-K · Nov 18, 2025
- Lite Strategy Pivots to Litecoin, Cuts Losses Amidst Treasury Shift — 10-Q · Nov 14, 2025
- Lite Strategy Inc. Announces Director Changes and Officer Compensation — 8-K · Oct 30, 2025
- Lite Strategy Pivots to Crypto with $100M Litecoin Treasury — 10-K · Sep 26, 2025
- Lite Strategy, Inc. Reports Unregistered Equity Sales — 8-K · Sep 15, 2025
- MEI Pharma Files 8-K with Corporate Updates — 8-K · Sep 10, 2025
- MEI Pharma Enters Material Definitive Agreement — 8-K · Sep 4, 2025
- MEI Pharma Appoints New CFO and Directors — 8-K · Aug 6, 2025
- MEI Pharma Files 8-K with Financials and Other Events — 8-K · Aug 5, 2025
- MEI Pharma Reports Unregistered Equity Sale — 8-K · Jul 30, 2025
- MEI Pharma Announces Material Agreement Termination & Officer Changes — 8-K · Jul 22, 2025
- MEI Pharma Files Q3 2025 10-Q, Details Revenue and Agreements — 10-Q · May 13, 2025
- MEI Pharma Announces CMO Departure, Director Changes — 8-K · Mar 7, 2025
- MEI Pharma Files Q2 2025 10-Q — 10-Q · Feb 12, 2025
- MEI Pharma Files 8-K on Shareholder Vote Matters — 8-K · Jan 31, 2025